Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group.
about
Selective intestinal decontamination for the prevention of early bacterial infections after liver transplantationThe Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMVBacterial infection after liver transplantationPrimary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsLong-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsCytomegalovirus disease in African-American kidney transplant patientsDesign and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.Nonhuman primate infections after organ transplantation.Toll-like receptor signaling in transplantation.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Practical guidelines: lung transplantation in patients with cystic fibrosis.Clinical and microbiological epidemiology of early and late infectious complications among solid-organ transplant recipients requiring hospitalization.Infectious Complications Following Small Bowel Transplantation.Expression of recipient cytomegalovirus in immunosuppressed and xenotransplanted Macaca fascicularis may be related to more severe gastrointestinal lesions.Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for infectious complications.Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation.Pneumonia in immunocompromised patients: more than meets the eye.Infectious complications more than 1 year after liver transplantation: a 3-decade nationwide experience.Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantationManagement of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
P2860
Q26741221-B1C34D3B-0152-4D0B-9E57-4031C587B286Q26768481-B313D077-B185-4B45-90E1-77356B9A2BC9Q26991438-29DA470E-D6CA-4E63-9470-817089A91651Q33932079-B1CED86E-6709-4FAA-9CC4-AFDDC2DB57C9Q34646976-B76CCF7B-2B57-472A-83A4-014BD8B4734AQ35544428-6BCAD263-5015-495F-813C-A722D70C56DDQ36614140-FAEC0196-674C-4BFD-A651-B9628FB22924Q36840924-5E173D5A-F59D-4651-BF1A-D4830F85D8E9Q36925928-A2E3F511-F8F1-4787-A03B-44D76C993E5DQ37236946-934A35DE-ECDE-4527-8946-AE6CDD83B80CQ37650317-AB30BCDD-FF11-428F-8DC0-91D207EACAD8Q37706330-B46F7C01-B23A-4B6D-92EC-503C0B535184Q40101877-B61262DD-2EEA-4090-89B1-9AFE18821834Q40912977-53D3B238-5384-491D-A96C-3D716114A1F6Q41482527-6CA505CF-29DA-4DDE-8621-12014BDE4CF0Q41744581-2A9E0502-8EE1-4A02-9184-A7628F98074BQ42206788-CAA4605A-C99D-4F5E-8EAD-2785ED53F8BAQ42216221-9D42D53C-2E06-4C34-BEA7-75CF314E141EQ42237229-694A1C85-96FC-4C2E-8C0B-6A42002A0499Q42992322-2314FEA1-1F86-495A-9E9B-E245AFC09612Q53130336-BD619930-5988-42AA-BFC6-31C7F1AE59EDQ54372506-9FE368EF-462C-4647-A33B-12CE399C9232Q57569086-85B42B8C-BC62-4F2D-970B-5D7F9A9B3EDBQ57815117-F109636E-3C52-403B-B5BF-584F2CA7FDC4
P2860
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Incidence, clinical characteri ...... from the RESITRA study group.
@ast
Incidence, clinical characteri ...... from the RESITRA study group.
@en
type
label
Incidence, clinical characteri ...... from the RESITRA study group.
@ast
Incidence, clinical characteri ...... from the RESITRA study group.
@en
prefLabel
Incidence, clinical characteri ...... from the RESITRA study group.
@ast
Incidence, clinical characteri ...... from the RESITRA study group.
@en
P2093
P2860
P1476
Incidence, clinical characteri ...... from the RESITRA study group.
@en
P2093
C Díaz-Pedroche
F López-Medrano
J M Aguado
J Torre-Cisneros
M Lizasoain
R San Juan
P2860
P304
P356
10.1111/J.1600-6143.2006.01694.X
P407
P577
2007-04-01T00:00:00Z